Article

Clinical and cost-effectiveness analysis of community-based screening strategies for non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

2022-10-05

Abstract excerpt

<title>Abstract</title> <p>Background & Aims: We investigated the prevalence of non-alcoholic fatty liver disease(NAFLD) in patients with type 2 diabetes mellitus(T2DM) in primary care and developed a risk-stratification pathway. We also assessed the cost-utility of different screening strategies for NAFLD in the diabetic community. Methods Consecutive T2DM patients underwent screening for liver diseases, inclu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f4b4cd98-0cf5-5261-b3de-b2e238c9251b
DOI: 10.21203/rs.3.rs-2135338/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical and cost-effectiveness analysis of community-based screening strategies for non-alcoholic fatty liver disease in patients with type-2 diabetes mellitusDOI 10.21203/rs.3.rs-2135338/v1Read

Proactive case-finding and risk-stratification in people at risk of chronic liver disease in Greater Manchester: a cost-effectiveness analysisSemantic proximity Read

Investigating the natural history of liver disease in type 2 diabetes and predicting the risk of its progression to advanced diseaseSemantic proximity Read

Markov Chains Analyzing Dataset of Patients with Metabolic Associated Fatty Liver DiseaseSemantic proximity Read

ADVANCED ARTIFICIAL INTELLIGENCE ENABLED METHODS FOR EARLY DETECTION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ASSOCIATED HEALTH RISKSSemantic proximity Read

Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.Semantic proximity Read

External Validation and Clinical Utility of Non-Invasive Prediction Models for Non-Alcoholic Fatty Liver Disease in MalaysiaSemantic proximity Read

An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis.Semantic proximity Read

Cost-effectiveness and population outcomes of general population screening for hepatitis C.Semantic proximity Read

Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver diseaseSemantic proximity Read

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.Semantic proximity Read

Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness resultsSemantic proximity Read

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals.Semantic proximity Read